LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Panacos Attracts $18.3M Round To Fund HIV Drug Development (BioWorld Today)
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.